Position in GERN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,071,352
-$223,597 QoQ
Shares Held
1,618,246
+5.1% QoQ
Ownership
0.252%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 258 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. GERN ranks #147 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in GERN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,071,352 | 1,618,246 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,294,949 | 1,540,236 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,077,462 | 1,573,836 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,157,397 | 1,574,744 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,304,517 | 1,634,410 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $2,607,302 | 1,639,814 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $5,838,952 | 1,649,422 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $7,532,053 | 1,659,043 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,550,476 | 2,016,622 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $5,282,437 | 1,600,739 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $3,737,115 | 1,771,145 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $3,420,096 | 1,613,253 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $5,239,242 | 1,632,163 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $3,045,574 | 1,403,491 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $3,053,647 | 1,261,838 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,882,802 | 1,231,967 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,803,634 | 1,163,636 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,579,262 | 1,161,223 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,402,204 | 1,149,349 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,532,123 | 1,118,339 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,448,223 | 1,027,109 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,947,461 | 1,232,571 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,960,794 | 1,233,205 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,974,155 | 1,134,573 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,102,147 | 964,288 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $998,364 | 838,962 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||